Wed Sep 03 04:30:00 UTC 2025: Okay, here’s a news article summarizing the Amanta Healthcare IPO based on the provided information:

**Headline: Amanta Healthcare IPO Oversubscribed, Shares Expected to List at ₹151**

**[City, Date]** – Amanta Healthcare’s initial public offering (IPO), which closed on September 1st, has garnered strong investor interest, being oversubscribed 4.6 times. The IPO, aimed at raising ₹126 crore, saw particularly robust demand from retail investors, who subscribed 6.7 times the shares allocated to them. Non-institutional investors also displayed keen interest, while institutional investor participation was comparatively muted.

The company offered 1 crore shares within a price band of ₹120 to ₹126 per share, with a minimum application size of 119 shares (approximately ₹15,000). Market analysts anticipate the shares will list on the stock exchange at around ₹151, a premium of roughly 20% over the IPO price.

Amanta Healthcare plans to utilize the IPO proceeds for the construction of new manufacturing facilities and procurement of advanced equipment in Gujarat, as well as for other general corporate purposes. The company specializes in manufacturing advanced liquid pharmaceuticals using sophisticated technology.

Beeline Capital Advisors served as the manager for the IPO.

*While the IPO has witnessed strong demand, potential investors are strongly advised to conduct thorough due diligence and carefully evaluate the company’s fundamentals before making any investment decisions.*

Read More